N. Dumont

发表

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

A. Gottlieb, S. Au, P. Scheinman, 2012, Journal of drugs in dermatology : JDD.

The Comparative Efficacy of Traditional Systemic, Biologic, and Combination Therapies in the Treatment of Psoriasis: An Expansion Study

A. Gottlieb, S. Au, N. Dumont, 2015 .

Association between pediatric psoriasis and the metabolic syndrome.

A. Gottlieb, M. Natter, P. Lizzul, 2012, Journal of American Academy of Dermatology.

CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial.

A. Gottlieb, M. Suárez-Fariñas, J. Krueger, 2015, JAMA dermatology.

A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis

D. Rosmarin, P. Zancanaro, N. Dumont, 2019, Journal of the American Academy of Dermatology.

Concomitant atopic dermatitis and psoriasis – a retrospective review

K. Barry, D. Rosmarin, P. Zancanaro, 2019, The Journal of dermatological treatment.

A retrospective review of dupilumab and psoriasis biologic combination therapy

K. Barry, D. Rosmarin, P. Zancanaro, 2019, The Journal of dermatological treatment.

Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skin.

A. Gottlieb, M. Suárez-Fariñas, J. Krueger, 2016, Journal of dermatological science.

Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Results of an Open-Label Trial.

A. Gottlieb, A. Saraiya, S. Au, 2020, Journal of the American Academy of Dermatology.

Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa

A. Gottlieb, A. Saraiya, D. Rosmarin, 2019, The British journal of dermatology.

Apremilast in Combination With an Interleukin 17A Inhibitor in the Treatment of Recalcitrant Palmoplantar Psoriasis

A. Gottlieb, D. Rosmarin, M. Her, 2018, Journal of Psoriasis and Psoriatic Arthritis.

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

A. Gottlieb, V. Huang, A. Saraiya, 2017, Journal of the American Academy of Dermatology.

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

A. Gottlieb, J. Kulig, P. Lizzul, 2013, Pediatric dermatology.

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

A. Gottlieb, P. Lizzul, Noori Kim, 2013, The Journal of dermatological treatment.

Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.

A. Gottlieb, N. Dumont, Eric P. Sorensen, 2015, Journal of drugs in dermatology : JDD.

Treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review

A. Gottlieb, D. Rosmarin, N. Dumont, 2019, Journal of drugs in dermatology : JDD.

Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: a single institutional retrospective medical record review.

D. Rosmarin, N. Dumont, S. Cohen, 2021, Journal of the American Academy of Dermatology.

A Retrospective Review of Dupilumab for Hand Dermatitis

D. Rosmarin, P. Zancanaro, N. Dumont, 2019, Dermatology.

Improving health literacy and treatment understanding of hidradenitis suppurativa using group educational interventions

A. Gottlieb, D. Rosmarin, P. Zancanaro, 2019, The Journal of dermatological treatment.

Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.

A. Gottlieb, Eshan A. Patvardhan, J. Kuvin, 2011, Journal of Drugs in Dermatology.

Apremilast 30 mg twice daily combined with dupilumab for the treatment of recalcitrant moderate‐to‐severe atopic dermatitis

D. Rosmarin, N. Dumont, S. Cohen, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

K. Shokat, R. Tisch, H. Mcdevitt, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Results of Switching From Tofacitinib to Upadacitinib in Patients With Atopic Dermatitis: A Retrospective Medical Record Review.

D. Rosmarin, N. Dumont, S. Cohen, 2021, Dermatitis : contact, atopic, occupational, drug.

Treatment of patients with atopic dermatitis with weekly dupilumab dosing: a single institutional retrospective medical record review and survey.

D. Rosmarin, N. Dumont, S. Cohen, 2021, Journal of American Academy of Dermatology.